ID
28042
Descripción
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Eligibility Question
Palabras clave
Versiones (4)
- 27/8/17 27/8/17 -
- 13/10/17 13/10/17 -
- 23/10/17 23/10/17 -
- 12/12/17 12/12/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
12 de diciembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Descripción
Inclusion Criteria
Descripción
Subject must understand the aims, investigational procedures and possible consequences of the study).
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021430
Descripción
Refer to Appendix 1: Highly Effective Methods For Avoidance Of Pregnancy In Women Of Childbearing Potential. The decision to include or exclude women of childbearing potential may be made at the discretion of the investigator in accordance with local practice in relation to adequate contraception.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0150831
- UMLS CUI [1,2]
- C0001779
Descripción
statin therapy
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0360714
Descripción
Chronic CHD documented by at least one of the following: a. prior MI (>1 month prior to randomisation). b. prior coronary revascularization procedure [percutaneous coronary intervention (PCI) > 1 month prior to randomization or coronary artery bypass graft (CABG) >3 months prior to randomization]. c. multivessel CHD involving major epicardial coronary arteries confirmed by coronary angiography at any time (without revascularization).
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0010068
Descripción
At least one of the following additional predictors of CV risk [a through f]: a. age >60 years at randomization. b. diabetes mellitus requiring pharmacothearpy. c. HDL-C <40 mg/dL (1.03 mmol/L). d. smoker (defined as at least 5 cigarettes per day on average) or a previous smoker (defined as at least 5 cigarettes per day on average when smoking) who discontinued within the past 3 months. e. significant renal dysfunction (defined as estimated glomerular filtration rate [eGFR] >30 and <59 mL/min per 1.73 m2 OR urine ACR >30 mg albumin/g creatinine). f. polyvascular disease manifested as coexistent clinically diagnosed arterial disease in at least 2 arterial territories, defined as: > chronic CHD and cerebrovascular disease defined as carotid artery disease or prior ischemic stroke >3 months. OR > chronic CHD and peripheral arterial disease (PAD).
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0850624
Descripción
Exclusion Criteria
Descripción
Planned coronary revascularization
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0877341
Descripción
Current liver disease, known hepatic or biliary abnormalities (with the exception of Gilbert's syndrome or asymptomatic gallstones) or evidence of abnormal liver function test [total bilirubin or alkaline phosphatase >1.5 x upper limit of normal (ULN); or ALT or AST >2.5 x ULN] or other hepatic abnormalities that in the opinion of the Investigator would preclude the subject from participation in the study.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0023895
Descripción
renal impairment
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1565489
Descripción
heart failure
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0018801
Descripción
hypertension
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0020538
Descripción
(e.g., very severe chronic airways disease, known human immunodeficiency virus [HIV] positive, or cancer in the past five years other than non-melanoma skin cancer).
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2826244
- UMLS CUI [1,2]
- C0012634
Descripción
asthma
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0004096
Descripción
All female subjects of childbearing potential must have a urine ß?-human chorionic gonadotropin [hCG] pregnancy test performed at Screening and/or within 7 days prior to randomization.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0032961
Descripción
Refer to Appendix 2: Clinical criteria for diagnosing anaphylaxis [Sampson, 2006]
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0002792
Descripción
Alcohol or drug abuse
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0038586
Descripción
intake CYP3A4 inhibitors
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3830624
Descripción
Lp-PLA2 activity
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0031671
Descripción
exposure to darapladib
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2348075
Descripción
Use of another investigational product
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0304229
Descripción
study of investigational device
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2346570
Descripción
other reason for exclusion
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C3840932
Similar models
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
C0001779 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,2])